Subscribe and receive the latest insights on the health and nutrition industry.
Join 37,000+ members. Yes, it's completely free.
In this wide-ranging podcast interview, Venable attorneys Michelle Jackson and Michael Blume--a former Justice Department official--weigh in on such topics as FDA regulations under the Trump administration, a criminal prosecution against USPlabs, a pending appeal over the legality of DMAA in dietary supplements, and recommendations for responding to a government investigation.
In this wide-ranging podcast interview with Josh Long, INSIDER's legal editor, Venable attorneys Michelle Jackson and Michael Blume—a former official with the U.S. Department of Justice (DOJ)—discuss:
-- Factors that influenced DOJ’s enforcement sweep announced in 2015 against unlawful activity in the dietary supplement industry;
-- FDA regulations under the Trump administration and 2016 draft new dietary ingredient (NDI) guidance adopted by FDA;
-- Considerations that could result in DOJ not adopting an FDA recommendation to proceed with court action;
-- A criminal prosecution against USPlabs;
-- A pending appeal over the legality of DMAA in dietary supplements; and
-- Recommendations for responding to a government investigation.
Jackson and Blume will be speaking on Tuesday, Sept. 26, during a workshop at SupplySide West in Las Vegas. The workshop “FDA Lawsuits and Class Action Litigation,” will explore FDA’s years-long court battle over the legality of DMAA, regulatory strategies to establish the safety of a new ingredient, an update on class action litigation, and tips to defend against lawsuits brought by regulators and the private plaintiffs’ bar.
About the Author(s)
You May Also Like
Recommended
.png?width=800&auto=webp&quality=80&disable=upscale)